Management of idiopathic thrombocytopenic purpura in pregnancy

Seminars in Hematology

Volumn 37, Issue 3, 2000, Pages 275-289

  Gill, Karamjit K ^a   Kelton, John G ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DANAZOL; DEXAMETHASONE; FERROUS SULFATE PLUS FOLIC ACID; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MULTIVITAMIN; PREDNISONE; THROMBOCYTE ANTIBODY; VINCRISTINE;

ARTICLE; BLOOD CELL COUNT; CLINICAL TRIAL; DELIVERY; DRUG INDUCED DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL LITERATURE; META ANALYSIS; NEWBORN CARE; NEWBORN DISEASE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTE COUNT;

EID: 0033852174     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90106-9     Document Type: Article

References (73)

1. Accurate intrapartum estimation of fetal platelet count by fetal scalp sample smear
2. Retrospective analysis of platelet numbers and volumes in normal pregnancy
3. Pregnancy-associated thrombocytopenia revisited: Assessment and follow-up of 50 cases
4. Outcome of pregnancy in women with idiopathic thrombocytopenic purpura
5. Risk of thrombocytopenia in the infants of mothers with idiopathic thrombocytopenia
6. Alloimmune neonatal thrombocytopenia associated with incidental maternal thrombocytopenia
7. A prospective study investigating the mechanism of thrombocytopenia in preeclampsia
8. Fetal thrombocytopenia and its relation to maternal thrombocytopenia
9. Incidentally detected thrombocytopenia in healthy mothers and their infants
10. Platelets and pregnancy
11. Thrombocytopenia at delivery: A prospective survey of 6715 deliveries
12. Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura
13. Pregnancy in patients with idiopathic thrombocytopenic purpura: Assessing the risks for the infant at delivery
14. Birth platelet counts in sequential newborns of mothers with ITP: Do the platelet counts change with subsequent babies?
15. Fetal alloimmune thrombocytopenia
16. Idiopathic thrombocytopenic purpura in pregnancy treated with pulsed high-dose oral dexamethsaone
17. Spontaneous resolution of pre-eclampsia-related thrombocytopenia
18. Comparison ofplatelet counts in first and second newborns of mothers with immune thrombocytopenic purpura
19. Idiopathic thrombocytopenic purpura in pregnancy: A randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count
20. A review of eclampsia in Melbourne: 1978-1992
21. Immune thrombocytopenic purpura and pregnancy
22. Immune thrombocytopenic purpura in pregnancy: A reappraisal of management
23. Platelets in pregnancy: Hyperdestruction in pregnancy
24. Pregnancy-associated autoimmune neonatal thrombocytopenia: Role of matemal HLA genotype
25. The role of percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpuna
26. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
27. Autoimmune diseases in pregnancy: Their effect on the fetus and newborn
28. Splenectomy during pregnancy: An option in the treatment of autoimmune thrombocytopenic purpura
29. An epidemic of maternal thrombocytopenia associated with elevated antiplatelet antibodies, platelet count and antiplatelet antibodies in 116 consecutive pregnancies: Relationship to neonatal platelet count
30. Spectrum of Ig classes, specificites, and titres of serum antiglycoproteins in chronic idiopathic thrombcytopenic purpura
31. Fetal thrombocytopenia: A retrospective survey of 5,194 fetal blood samplings
32. Review of autoimmune thrombocytopenia: Pathogenesis, diagnosis, and management in pregnancy
33. Fetal platelet counts in thrombocytopenic pregnancy
34. Maternal thrombocytopenia during pregnancy: Diagnosis and etiology
35. Platelet counts in infants of women with autoimmune thrombocytopenia
36. The natural history of thrombocytopenia associated with preeclampsia
37. The serological investigation of patients with autoimmune thrombocytopenia
38. Management of the pregnant patient with idiopathic thrombocytopenic purpura
39. Route of delivery for patients with immune thrombocytopenic purpura
40. Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task Force of the British Society for Haematology
41. Postpartum corticosteroids: Accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP)
42. Plasma exchange for preeclampsia. I. Postpartum use for persistently severe preeclampsia-eclampsia with HELLP syndrome
43. Pregnancy complicated by preeclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet count: How rapid is postpartum recovery?
44. Autoimmune thrombocytopenic purpura in pregnancy: Maternal risk factors predictive of neonatal thrombocytopenia
45. Pregnancy-associated thrombocytopenia: Pathogenesis and management
46. Discordant fetal platelet counts in a twin gestation complicated by idiopathic thrombocytopenic purpura
47. Percutaneous umbilical cord blood sampling in the evaluation of fetal platelet counts in pregnant patients with autoimmune thrombocytopenia purpura
48. Pregnancy in women with immune thrombocytopenic purpura
49. Preeclampsia effect on platelet count
50. Autoimmune thrombocytopenic purpura: Maternal and fetal disease
51. Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia
52. Perinatal management of women with immune thrombocytopenic purpura: Survey of United States perinatologists
53. Unrecognized thrombocytopenia and regional anesthesia in parturients: A retrospective review
54. Epidural analgesia in pregnant patients with low platelet counts
55. Acute fatty liver of pregnancy: A clinical study of 12 episodes in 11 patients
56. Idiopathic thrombocytopenic purpura in pregnancy
57. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura
58. Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: A review of diagnosis and management
59. The use of percutaneous umbilical cord sampling in immune thrombocytopenic purpura
60. Low fetal morbidity in pregnancy associated with acute and chronic idiopathic thrombocytopenic purpura
61. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Much ado about nothing
62. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: A randomized controlled trial
63. Prevention of preeclampsia: A big disappointment
64. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsiaeclampsia
65. Prevention of preeclampsia: A big disappointment
66. Scott J.R. Maternal thrombocytopenia in pregnancy: Time for a reassessment
67. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations
68. Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocytopenia
69. Longitudinal analysis of platelet count and volume in normal pregnancy
70. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy
71. Counseling for women with preeclampsia or eclampsia
72. Perinatal management of idiopathic thrombocytopenic purpura in pregnancy: Risk factors for passive immune thrombocytopenia
73. Risk factors for neonatal thrombocytopenia in pregnancy complicated by idiopathic thrombocytopenic purpura